Endothelial cell polarization and chemotaxis in a microfluidic device

Lab on a Chip ◽  
2008 ◽  
Vol 8 (8) ◽  
pp. 1292 ◽  
Author(s):  
Amir Shamloo ◽  
Ning Ma ◽  
Mu-ming Poo ◽  
Lydia L. Sohn ◽  
Sarah C. Heilshorn
Lab on a Chip ◽  
2020 ◽  
Vol 20 (23) ◽  
pp. 4373-4390
Author(s):  
Utku M. Sonmez ◽  
Ya-Wen Cheng ◽  
Simon C. Watkins ◽  
Beth L. Roman ◽  
Lance A. Davidson

Endothelial cell polarization and orientation analysis using a novel microfluidic device that can simultaneously generate multiple levels of shear stress and shear stress gradients for systematic mechanobiology studies under flow.


2004 ◽  
Vol 280 (5) ◽  
pp. 3541-3547 ◽  
Author(s):  
Andrew Beardsley ◽  
Kai Fang ◽  
Heather Mertz ◽  
Vince Castranova ◽  
Sherri Friend ◽  
...  

2005 ◽  
Vol 19 (6) ◽  
pp. 1-23 ◽  
Author(s):  
Maria Philippova ◽  
Danila Ivanov ◽  
Roy Allenspach ◽  
Yoh Takuwa ◽  
Paul Erne ◽  
...  

eLife ◽  
2018 ◽  
Vol 7 ◽  
Author(s):  
Maud Martin ◽  
Alexandra Veloso ◽  
Jingchao Wu ◽  
Eugene A Katrukha ◽  
Anna Akhmanova

Microtubules control different aspects of cell polarization. In cells with a radial microtubule system, a pivotal role in setting up asymmetry is attributed to the relative positioning of the centrosome and the nucleus. Here, we show that centrosome loss had no effect on the ability of endothelial cells to polarize and move in 2D and 3D environments. In contrast, non-centrosomal microtubules stabilized by the microtubule minus-end-binding protein CAMSAP2 were required for directional migration on 2D substrates and for the establishment of polarized cell morphology in soft 3D matrices. CAMSAP2 was also important for persistent endothelial cell sprouting during in vivo zebrafish vessel development. In the absence of CAMSAP2, cell polarization in 3D could be partly rescued by centrosome depletion, indicating that in these conditions the centrosome inhibited cell polarity. We propose that CAMSAP2-protected non-centrosomal microtubules are needed for establishing cell asymmetry by enabling microtubule enrichment in a single-cell protrusion.


2015 ◽  
pp. 205-220 ◽  
Author(s):  
George E. Davis ◽  
Katherine R. Speichinger ◽  
Pieter R. Norden ◽  
Dae Joong Kim ◽  
Stephanie L. K. Bowers

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Ana Carolina Urbaczek ◽  
Paulo Augusto Gomes Carneiro Leão ◽  
Fayene Zeferino Ribeiro de Souza ◽  
Ana Afonso ◽  
Juliana Vieira Alberice ◽  
...  

1998 ◽  
Vol 141 (3) ◽  
pp. 791-804 ◽  
Author(s):  
María Yáñez-Mó ◽  
Arántzazu Alfranca ◽  
Carlos Cabañas ◽  
Mónica Marazuela ◽  
Reyes Tejedor ◽  
...  

Cell-to-cell junction structures play a key role in cell growth rate control and cell polarization. In endothelial cells (EC), these structures are also involved in regulation of vascular permeability and leukocyte extravasation. To identify novel components in EC intercellular junctions, mAbs against these cells were produced and selected using a morphological screening by immunofluorescence microscopy. Two novel mAbs, LIA1/1 and VJ1/16, specifically recognized a 25-kD protein that was selectively localized at cell–cell junctions of EC, both in the primary formation of cell monolayers and when EC reorganized in the process of wound healing. This antigen corresponded to the recently cloned platelet-endothelial tetraspan antigen CD151/PETA-3 (platelet-endothelial tetraspan antigen-3), and was consistently detected at EC cell–cell contact sites. In addition to CD151/PETA-3, two other members of the tetraspan superfamily, CD9 and CD81/ TAPA-1 (target of antiproliferative antibody-1), localized at endothelial cell-to-cell junctions. Biochemical analysis demonstrated molecular associations among tetraspan molecules themselves and those of CD151/ PETA-3 and CD9 with α3β1 integrin. Interestingly, mAbs directed to both CD151/PETA-3 and CD81/ TAPA-1 as well as mAb specific for α3 integrin, were able to inhibit the migration of ECs in the process of wound healing. The engagement of CD151/PETA-3 and CD81/TAPA-1 inhibited the movement of individual ECs, as determined by quantitative time-lapse video microscopy studies. Furthermore, mAbs against the CD151/PETA-3 molecule diminished the rate of EC invasion into collagen gels. In addition, these mAbs were able to increase the adhesion of EC to extracellular matrix proteins. Together these results indicate that CD81/TAPA-1 and CD151/PETA-3 tetraspan molecules are components of the endothelial lateral junctions implicated in the regulation of cell motility, either directly or by modulation of the function of the associated integrin heterodimers.


2021 ◽  
Author(s):  
Hyojin Park ◽  
Jessica Furtado ◽  
Mathilde Poulet ◽  
Minhwan Chung ◽  
Sanguk Yun ◽  
...  

Background: Activin receptor-like kinase 1 (ACVRL1, hereafter ALK1) is an endothelial transmembrane serine threonine kinase receptor for BMP family ligands that plays a critical role in cardiovascular development and pathology. Loss-of-function mutations in the ALK1 gene cause type 2 hereditary hemorrhagic telangiectasia (HHT), a devastating disorder that leads to arteriovenous malformations (AVMs). Here we show that ALK1 controls endothelial cell polarization against the direction of blood flow and flow-induced endothelial migration from veins through capillaries into arterioles. Methods: Using Cre lines that recombine in different subsets of arterial, capillary-venous or endothelial tip cells, we showed that capillary-venous Alk1 deletion was sufficient to induce AVM formation in the postnatal retina. Results: ALK1 deletion impaired capillary-venous endothelial cell polarization against the direction of blood flow in vivo and in vitro. Mechanistically, ALK1 deficient cells exhibited increased integrin signaling interaction with VEGFR2, which enhanced downstream YAP/TAZ nuclear translocation. Pharmacological inhibition of integrin or YAP/TAZ signaling rescued flow migration coupling and prevented vascular malformations in Alk1 deficient mice. Conclusions: Our study reveals ALK1 as an essential driver of flow-induced endothelial cell migration and identifies loss of flow-migration coupling as a driver of AVM formation in HHT disease. Integrin-YAP/TAZ signaling blockers are new potential targets to prevent vascular malformations in HHT patients.


2016 ◽  
Vol 48 (12) ◽  
pp. 1138-1139 ◽  
Author(s):  
Hong Zhao ◽  
Pingbo Yao ◽  
Lanfang Li ◽  
Linxi Chen

Sign in / Sign up

Export Citation Format

Share Document